CATALYST PHARMACEUTICALS INC filings

SEC filings by CATALYST PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13VANGUARD GROUP INCCATALYST PHARMACEUTICALS, INC.7,120,4176.7%EDGAR
SC 13G/A2024-02-12Flynn James ECATALYST PHARMACEUTICALS, INC.8,888,9018.3%EDGAR
SC 13G/A2024-01-25STATE STREET CORPCATALYST PHARMACEUTICALS, INC.-6.4%EDGAR
SC 13G/A2024-01-22BlackRock Inc.CATALYST PHARMACEUTICALS, INC.15,821,40114.8%EDGAR
SC 13G/A2023-02-14ARMISTICE CAPITAL, LLCCATALYST PHARMACEUTICALS, INC.00.0%EDGAR
SC 13G/A2023-02-10Flynn James ECATALYST PHARMACEUTICALS, INC.5,884,4485.6%EDGAR
SC 13G2023-02-09VANGUARD GROUP INCCATALYST PHARMACEUTICALS, INC.6,768,7416.5%EDGAR
SC 13G/A2023-02-08STATE STREET CORPCATALYST PHARMACEUTICALS, INC.-7.6%EDGAR
SC 13G/A2023-01-26BlackRock Inc.CATALYST PHARMACEUTICALS, INC.15,690,32615.1%EDGAR
SC 13G/A2023-01-20BlackRock Inc.CATALYST PHARMACEUTICALS, INC.15,690,32615.1%EDGAR
SC 13G2022-11-14Flynn James ECATALYST PHARMACEUTICALS, INC.6,060,4915.8%EDGAR
SC 13G/A2022-10-07BlackRock Inc.CATALYST PHARMACEUTICALS, INC.15,268,93114.9%EDGAR
SC 13G/A2022-02-15ARMISTICE CAPITAL, LLCCATALYST PHARMACEUTICALS, INC.9,572,0009.3%EDGAR
SC 13G/A2022-02-09STATE STREET CORPCATALYST PHARMACEUTICALS, INC.-4.9%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCCATALYST PHARMACEUTICALS, INC.4,836,3134.7%EDGAR
SC 13G/A2022-02-03BlackRock Inc.CATALYST PHARMACEUTICALS, INC.7,684,6987.5%EDGAR
SC 13G/A2021-02-16ARMISTICE CAPITAL, LLCCATALYST PHARMACEUTICALS, INC.10,000,0009.7%EDGAR
SC 13G2021-02-10VANGUARD GROUP INCCATALYST PHARMACEUTICALS, INC.5,771,0795.6%EDGAR
SC 13G2021-02-05STATE STREET CORPCATALYST PHARMACEUTICALS, INC.-5.9%EDGAR
SC 13G/A2021-01-29BlackRock Inc.CATALYST PHARMACEUTICALS, INC.7,744,1977.5%EDGAR